Alexion Pharmaceuticals Biotech News Portfolio

FDA Approves Alexion’s Ravulizumab for Atypical Hemolytic Uremic Syndrome

Biotech News | 19.10.2019

The US healthcare authority FDA on Friday approved Alexion Pharmaceuticals’ drug Ravulizumab for...

Alexion Pharmaceuticals Biotech News Portfolio

Alexion with $930 Million Takeover of Achillion Pharmaceuticals to Expand Drug Pipeline for Rare Immunological Diseases

Biotech News | 16.10.2019

The big merger and acquisition (M&A) wave in biotech industry continues. Alexion...

Alexion Pharmaceuticals Biotech News Portfolio

Takeover Rumors Boost Alexion Pharmaceuticals Share

Biotech News | 23.08.2019

The share price of our sample portfolio member Alexion Pharmaceuticals exploded this week. The...